NRC vs PATH · P/E 46, rev $143.1M vs P/E 19, rev $1.61B
National Research Corp (NRC) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
National Research Corp (NRC) is a health information services company listed on NASDAQ.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported NRC revenue for 2024-12-31 was $143.1M. Net income was $24.8M. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. NRC currently screens at market cap $400.0M and trailing P/E 45.5.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
NRC currently screens at market cap $400.0M and trailing P/E 45.5. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the NRC and PATH stock pages for the full models.
Not investment advice.